Joaquim José Coutinho Ferreira
AuthID: R-000-7JF
141
TÃTULO: The Prevalence and Determinants of Neuropsychiatric Symptoms in Late-Stage Parkinsonism
AUTORES: Hommel, ALAJ; Meinders, MJ; Lorenzl, S; Dodel, R; Coelho, M; Ferreira, JJ; Laurens, B; Spampinato, U; Meissner, W; Rosqvist, K; Timpka, J; Odin, P; Wittenberg, M; PhD, BR; Koopmans, RT; Schrag, A;
PUBLICAÇÃO: 2020, FONTE: MOVEMENT DISORDERS CLINICAL PRACTICE, VOLUME: 7, NÚMERO: 5
AUTORES: Hommel, ALAJ; Meinders, MJ; Lorenzl, S; Dodel, R; Coelho, M; Ferreira, JJ; Laurens, B; Spampinato, U; Meissner, W; Rosqvist, K; Timpka, J; Odin, P; Wittenberg, M; PhD, BR; Koopmans, RT; Schrag, A;
PUBLICAÇÃO: 2020, FONTE: MOVEMENT DISORDERS CLINICAL PRACTICE, VOLUME: 7, NÚMERO: 5
142
TÃTULO: Burden of Care-Partners of People with Parkinson's disease: Findings from Parkinson's disease Real-World Impact Assessment (PRISM) Study Full Text
AUTORES: Tolosa, E; Ferreira, JJ; Antonini, A; Lees, A; Foltynie, T; Ebersbach, G; Rascol, O; Rocha, JF; Magalhaes, D; Soares Da Silva, P;
PUBLICAÇÃO: 2020, FONTE: 6th Congress of the European-Academy-of-Neurology (EAN) in EUROPEAN JOURNAL OF NEUROLOGY, VOLUME: 27
AUTORES: Tolosa, E; Ferreira, JJ; Antonini, A; Lees, A; Foltynie, T; Ebersbach, G; Rascol, O; Rocha, JF; Magalhaes, D; Soares Da Silva, P;
PUBLICAÇÃO: 2020, FONTE: 6th Congress of the European-Academy-of-Neurology (EAN) in EUROPEAN JOURNAL OF NEUROLOGY, VOLUME: 27
INDEXADO EM: 
WOS
WOS143
TÃTULO: Efficacy and safety of opicapone in Parkinson's disease patients according to duration of motor fluctuations: post-hoc analysis of BIPARK-I and II Full Text
AUTORES: Ebersbach, G; Rascol, O; Ferreira, JJ; Costa, R; Rocha, JF; Magalhaes, D; Soares Da Silva, P;
PUBLICAÇÃO: 2020, FONTE: 6th Congress of the European-Academy-of-Neurology (EAN) in EUROPEAN JOURNAL OF NEUROLOGY, VOLUME: 27
AUTORES: Ebersbach, G; Rascol, O; Ferreira, JJ; Costa, R; Rocha, JF; Magalhaes, D; Soares Da Silva, P;
PUBLICAÇÃO: 2020, FONTE: 6th Congress of the European-Academy-of-Neurology (EAN) in EUROPEAN JOURNAL OF NEUROLOGY, VOLUME: 27
INDEXADO EM: WOS
WOS144
TÃTULO: Change in OFF-/ON-Time After Switching from Double-Blind Entacapone or Placebo to Open-Label Opicapone in Patients who Ended the 1-Year BIPARK-I Extension Study on Opicapone 50mg Full Text
AUTORES: Poewe, W; Ferreira, JJ; Lees, A; Rascol, O; Ikedo, F; Magalhaes, D; Rocha, JF; Soares Da Silva, P;
PUBLICAÇÃO: 2020, FONTE: 6th Congress of the European-Academy-of-Neurology (EAN) in EUROPEAN JOURNAL OF NEUROLOGY, VOLUME: 27
AUTORES: Poewe, W; Ferreira, JJ; Lees, A; Rascol, O; Ikedo, F; Magalhaes, D; Rocha, JF; Soares Da Silva, P;
PUBLICAÇÃO: 2020, FONTE: 6th Congress of the European-Academy-of-Neurology (EAN) in EUROPEAN JOURNAL OF NEUROLOGY, VOLUME: 27
INDEXADO EM: WOS
WOS145
TÃTULO: Efficacy of Opicapone in Patients with Parkinson's Disease with Levodopa Dose Reduction: a Pooled Post-Hoc Analysis of BIPARK-I and II Full Text
AUTORES: Rascol, O; Poewe, W; Ferreira, JJ; Lees, A; Santos, AT; Magalhaes, D; Rocha, JF; Soares Da Silva, P;
PUBLICAÇÃO: 2020, FONTE: 6th Congress of the European-Academy-of-Neurology (EAN) in EUROPEAN JOURNAL OF NEUROLOGY, VOLUME: 27
AUTORES: Rascol, O; Poewe, W; Ferreira, JJ; Lees, A; Santos, AT; Magalhaes, D; Rocha, JF; Soares Da Silva, P;
PUBLICAÇÃO: 2020, FONTE: 6th Congress of the European-Academy-of-Neurology (EAN) in EUROPEAN JOURNAL OF NEUROLOGY, VOLUME: 27
INDEXADO EM: WOS
WOS146
TÃTULO: Reader response: Risk factors for suicidality in Huntington disease: An analysis of the 2CARE clinical trial
AUTORES: Rato, ML; Ferreira, JJ;
PUBLICAÇÃO: 2020, FONTE: NEUROLOGY, VOLUME: 94, NÚMERO: 14
AUTORES: Rato, ML; Ferreira, JJ;
PUBLICAÇÃO: 2020, FONTE: NEUROLOGY, VOLUME: 94, NÚMERO: 14
147
TÃTULO: Strategies to minimize placebo effects in research investigations
AUTORES: Rodrigues, FB; Ferreira, JJ;
PUBLICAÇÃO: 2020, FONTE: PLACEBO EFFECTS IN NEUROLOGIC DISEASE, VOLUME: 153
AUTORES: Rodrigues, FB; Ferreira, JJ;
PUBLICAÇÃO: 2020, FONTE: PLACEBO EFFECTS IN NEUROLOGIC DISEASE, VOLUME: 153
148
TÃTULO: Guidelines on exercise testing and prescription for patients at different stages of Parkinson's disease
AUTORES: Martignon, C; Pedrinolla, A; Ruzzante, F; Giuriato, G; Laginestra, FG; Bouca Machado, R; Ferreira, JJ; Tinazzi, M; Schena, F; Venturelli, M;
PUBLICAÇÃO: 2020, FONTE: AGING CLINICAL AND EXPERIMENTAL RESEARCH, VOLUME: 33, NÚMERO: 2
AUTORES: Martignon, C; Pedrinolla, A; Ruzzante, F; Giuriato, G; Laginestra, FG; Bouca Machado, R; Ferreira, JJ; Tinazzi, M; Schena, F; Venturelli, M;
PUBLICAÇÃO: 2020, FONTE: AGING CLINICAL AND EXPERIMENTAL RESEARCH, VOLUME: 33, NÚMERO: 2
149
TÃTULO: Neuromelanin Magnetic Resonance Imaging of the Substantia Nigra in Huntington's Disease
AUTORES: Leitao, R; Guerreiro, C; Nunes, RG; Goncalves, N; Galati, G; Rosario, M; Guedes, LC; Ferreira, JJ; Reimao, S;
PUBLICAÇÃO: 2020, FONTE: JOURNAL OF HUNTINGTONS DISEASE, VOLUME: 9, NÚMERO: 2
AUTORES: Leitao, R; Guerreiro, C; Nunes, RG; Goncalves, N; Galati, G; Rosario, M; Guedes, LC; Ferreira, JJ; Reimao, S;
PUBLICAÇÃO: 2020, FONTE: JOURNAL OF HUNTINGTONS DISEASE, VOLUME: 9, NÚMERO: 2
INDEXADO EM: WOS
WOS NO MEU: 
ORCID
ORCID150
TÃTULO: Circulating Inflammatory miRNAs Associated with Parkinson's Disease Pathophysiology Full Text
AUTORES: Oliveira, SR; Dionisio, PA; Guedes, LC; Goncalves, N; Coelho, M; Rosa, MM; Amaral, JD; Ferreira, JJ; Rodrigues, CMP;
PUBLICAÇÃO: 2020, FONTE: BIOMOLECULES, VOLUME: 10, NÚMERO: 6
AUTORES: Oliveira, SR; Dionisio, PA; Guedes, LC; Goncalves, N; Coelho, M; Rosa, MM; Amaral, JD; Ferreira, JJ; Rodrigues, CMP;
PUBLICAÇÃO: 2020, FONTE: BIOMOLECULES, VOLUME: 10, NÚMERO: 6
